Erratum to: Vedolizumab: A Review of Its Use in Adult Patients with Moderately to Severely Active Ulcerative Colitis or Crohn’s Disease
Garnock-Jones, K. P.Volume:
29
Journal:
BioDrugs
DOI:
10.1007/s40259-015-0115-8
Date:
February, 2015
File:
PDF, 112 KB
2015